- Home
- BKH vs AXSM Comparison
BKH vs AXSM Comparison
Compare BKH & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKH
- AXSM
- Stock Information
- Founded
- BKH 1941
- AXSM 2012
- Country
- BKH United States
- AXSM United States
- Employees
- BKH N/A
- AXSM N/A
- Industry
- BKH Electric Utilities: Central
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- BKH Utilities
- AXSM Health Care
- Exchange
- BKH Nasdaq
- AXSM Nasdaq
- Market Cap
- BKH 4.3B
- AXSM 5.1B
- IPO Year
- BKH N/A
- AXSM 2015
- Fundamental
- Price
- BKH $56.78
- AXSM $102.65
- Analyst Decision
- BKH Hold
- AXSM Strong Buy
- Analyst Count
- BKH 3
- AXSM 16
- Target Price
- BKH $66.00
- AXSM $170.50
- AVG Volume (30 Days)
- BKH 561.5K
- AXSM 719.8K
- Earning Date
- BKH 07-30-2025
- AXSM 08-04-2025
- Dividend Yield
- BKH 4.76%
- AXSM N/A
- EPS Growth
- BKH N/A
- AXSM N/A
- EPS
- BKH 3.95
- AXSM N/A
- Revenue
- BKH $2,206,500,000.00
- AXSM $432,157,000.00
- Revenue This Year
- BKH $4.90
- AXSM $62.84
- Revenue Next Year
- BKH $3.27
- AXSM $60.02
- P/E Ratio
- BKH $14.36
- AXSM N/A
- Revenue Growth
- BKH 3.28
- AXSM 72.16
- 52 Week Low
- BKH $53.22
- AXSM $72.21
- 52 Week High
- BKH $65.59
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- BKH 40.80
- AXSM 48.53
- Support Level
- BKH $55.50
- AXSM $99.75
- Resistance Level
- BKH $56.39
- AXSM $106.60
- Average True Range (ATR)
- BKH 0.74
- AXSM 3.11
- MACD
- BKH 0.02
- AXSM 0.10
- Stochastic Oscillator
- BKH 24.31
- AXSM 44.39
About BKH Black Hills Corporation
Black Hills Corp is a U.S.-based energy company that operates through its Electric Utilities and Gas Utilities segment. These segments operate in states in the Midwest and mountain regions in the U.S. The company's customers include residential, commercial, industrial, and municipal consumers. These customers are residential. Black Hills derives the majority of its revenue from its utility business group, specifically from gas utilities.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.